Results 101 to 110 of about 39,159 (175)

Association between initial combination antiretroviral regimen (Lamivudine/Non-lamivudine) and time to attrition overall and stratified by calendar year of therapy initiation.

, 2012
Note: HR = hazard ratio; 95% CI = 95% Confidence Interval; † Includes initial regimen (lamivudine/Non-lamivudine) and patients’ age, gender, marriage status, HIV exposure category, CD4 cell counts, hemoglobin level, clinical symptoms, area of residence ...
Hao Zhu (56502), Stephen Cole (155332), Zhongfu Liu (155372), Decai Zhao (155378), Fujie Zhang (155391), Sonia Napravnik (155319), Joseph Eron (155324), David Wohl (155349), Ye Ma (155341), Myron Cohen (155383), Yao Zhang (134381), Zhihui Dou (155360)   +11 more
core   +1 more source

Population Pharmacokinetic Model for Adherence Evaluation Using Lamivudine Concentration Monitoring

, 2012
Background: Interpretation of antiretroviral drug concentration measurements could be aided by information about adherence to recent doses. We developed a population pharmacokinetic model of lamivudine in young children to propose reference lamivudine ...
Karlsson, Mats O.,, Denti, Paolo, van der Walt, Jan-Stefan, Zhang, Chao, McIlleron, Helen, Ren, Yuan, Smith, Peter   +6 more
core   +1 more source

Tratamiento prolongado con interferón alfa-2b más lamivudina en pacientes con hepatitis crónica B y antígeno e positivo Prolonged treatment with alpha-2b interferon plus lamivudine in patients with e antigen positive chronic hepatitis B

Revista Cubana de Medicina, 2007
Las tasas de seroconversión del antígeno e alcanzadas con los antivirales actuales no sobrepasan el 35 %. La combinación de inmunomodulador y antiviviral ha sido teóricamente la estrategia más aceptada en los últimos años; sin embargo, los resultados en ...
Eduardo Vilar Gómez, Bienvenido Grá Orama, Enrique Arús Soler, Caridad Ruenes Domech, Yudith Dávila González   +4 more
doaj  

Treatment of patients with chronic hepatitis b in General hospital Celje

Zdravniški Vestnik, 2005
Background: A third of world’s population has serological evidence of a past or current infection with hepatitis B virus and 350 million people have chronic infection. Chronic hepatitis B is associated with liver cirrhosis and hepatic cancer, i.e.
Gorazd Lešničar
doaj  

Treatment failure and associated factors among people living with HIV on second-line antiretroviral therapy in Zambia. [PDF]

Int Health
Sikambale K, Chanda C, Daka V, Kazonga E, Mudenda S.   +4 more
europepmc   +1 more source

The Influence of Plasma and Peritoneal Antiretroviral Drugs Levels on the Shedding of HIV-1 Into Peritoneal Dialysis Effluent. [PDF]

J Med Virol
Mooko T, Bisiwe F, Chikobvu P, Morobadi M, Nyaga M, Goedhals D, Mofokeng T, Kemp G, Ndlovu K.   +8 more
europepmc   +1 more source

Combining X‑ray Diffraction, Solid-State NMR, and Computational Chemistry for Structural Insights and Performance Evaluation of GIPAW/GIAO ¹³C Chemical-Shift Calculations for Lamivudine and Three Pharmaceutical Salts. [PDF]

ACS Omega
Dias-Silva JR, Ferreira VS, Martins FT, Lacerda Júnior V, de Souza PL, Marinho TMF, Queiroz Júnior LHK.   +6 more
europepmc   +1 more source

Pharmacokinetics of abacavir and lamivudine in infants living with HIV with and without rifampicin co-treatment. [PDF]

J Antimicrob Chemother
Beca LSDAB, Mumbiro V, Bwakura M, Mujuru HA, Mudzingwa S, Tagarro A, Domínguez-Rodríguez S, Musiime V, Nalwanga D, Buck WC, Sacarlal J, Chabala C, Chansa BN, Rojo P, Burger DM, Moraleda C, Jacobs TG, EMPIRICAL Clinical Trial Group.   +17 more
europepmc   +1 more source

Pharmaceutical Residues in Human Urine from Patients Under Antiretroviral Regimens and Self-Reported Healthy Individuals Before and After Three Months' Storage: Implication for Agricultural Reuse in Pretoria, South Africa. [PDF]

BioTech (Basel)
Lizbelt ML, Faith BK, Oladeji OM, Olatunji OS, Olowoyo JO.   +4 more
europepmc   +1 more source

Dynamics of spatiotemporal pharmacological models for hepatitis B virus infection under lamivudine and pegylated interferon alfa-2b therapies. [PDF]

BMC Infect Dis
Tchioffo BR, Mvogo A, Abiama PE.
europepmc   +1 more source